Axogen reports preliminary unaudited revenue for fourth quarter and full-year 2023

Alachua, fla. and tampa, fla., jan. 04, 2024 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2023 revenue.
AXGN Ratings Summary
AXGN Quant Ranking